Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation

Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation

BackgroundSeveral viral and bacterial infections, including COVID-19, may lead to both thrombotic and hemorrhagic complications. Previously, it has been demonstrated an “in vitro” pathogenic effect of “antiphospholipid” antibodies (aPLs), which are able to activate a proinflammatory and procoagulant...

Full description

Bibliographic Details
Main Authors: Antonella Capozzi, Gloria Riitano, Serena Recalchi, Valeria Manganelli, Agostina Longo, Anne Falcou, Manuela De Michele, Tina Garofalo, Fabio M. Pulcinelli, Maurizio Sorice, Roberta Misasi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
antiphospholipid antibodies
β2-GPI
COVID-19
thrombosis
stroke.
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129201/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129201/full

Similar Items